Raymond James & Associates’s Healthcare Services Group HCSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.12M Sell
369,137
-14,727
-4% -$162K ﹤0.01% 1782
2024
Q2
$4.06M Buy
383,864
+32,411
+9% +$360K ﹤0.01% 1733
2024
Q1
$4.39M Buy
351,453
+8,892
+3% +$98.6K ﹤0.01% 1685
2023
Q4
$3.55M Sell
342,561
-28,868
-8% -$288K ﹤0.01% 1747
2023
Q3
$3.87M Sell
371,429
-44,462
-11% -$553K ﹤0.01% 1619
2023
Q2
$6.21M Sell
415,891
-25,367
-6% -$367K 0.01% 1338
2023
Q1
$6.12M Buy
441,258
+24,496
+6% +$323K 0.01% 1335
2022
Q4
$5M Sell
416,762
-12,744
-3% -$168K ﹤0.01% 1398
2022
Q3
$5.19M Sell
429,506
-1,175
-0.3% -$17.3K 0.01% 1356
2022
Q2
$7.5M Sell
430,681
-5,312
-1% -$91.6K 0.01% 1145
2022
Q1
$8.1M Sell
435,993
-1,406
-0.3% -$24.3K 0.01% 1193
2021
Q4
$7.78M Sell
437,399
-43,358
-9% -$843K 0.01% 1250
2021
Q3
$12M Sell
480,757
-26,654
-5% -$721K 0.01% 954
2021
Q2
$16M Sell
507,411
-3,958
-0.8% -$120K 0.01% 820
2021
Q1
$14.3M Buy
511,369
+5,210
+1% +$157K 0.01% 833
2020
Q4
$14.2M Sell
506,159
-24,586
-5% -$595K 0.02% 768
2020
Q3
$11.4M Buy
530,745
+18,507
+4% +$432K 0.01% 799
2020
Q2
$12.5M Sell
512,238
-81,515
-14% -$1.93M 0.02% 714
2020
Q1
$14.2M Sell
593,753
-44,596
-7% -$1.15M 0.02% 585
2019
Q4
$15.5M Buy
638,349
+27,400
+4% +$679K 0.02% 690
2019
Q3
$14.8M Buy
610,949
+103,360
+20% +$2.61M 0.02% 678
2019
Q2
$15.4M Buy
507,589
+20,631
+4% +$682K 0.02% 644
2019
Q1
$16.1M Sell
486,958
-2,711
-0.6% -$104K 0.02% 607
2018
Q4
$19.7M Sell
489,669
-296
-0.1% -$12.5K 0.03% 483
2018
Q3
$19.9M Buy
489,965
+33,737
+7% +$1.4M 0.03% 533
2018
Q2
$19.7M Sell
456,228
-2,493
-0.5% -$99K 0.03% 513
2018
Q1
$19.9M Buy
458,721
+15,047
+3% +$736K 0.04% 477
2017
Q4
$23.4M Buy
443,674
+535
+0.1% +$28K 0.04% 407
2017
Q3
$23.9M Buy
443,139
+2,175
+0.5% +$112K 0.05% 384
2017
Q2
$20.6M Sell
440,964
-738
-0.2% -$34.1K 0.04% 421
2017
Q1
$19M Buy
441,702
+3,173
+0.7% +$130K 0.04% 409
2016
Q4
$17.2M Buy
438,529
+609
+0.1% +$23.3K 0.04% 429
2016
Q3
$17.3M Buy
437,920
+387,301
+765% +$15.2M 0.05% 395
2016
Q2
$2.1M Sell
50,619
-10,681
-17% -$410K 0.01% 1305
2016
Q1
$2.26M Buy
61,300
+302
+0.5% +$10.5K 0.01% 1211
2015
Q4
$2.13M Sell
60,998
-614
-1% -$22.3K 0.01% 1228
2015
Q3
$2.08M Buy
61,612
+8,154
+15% +$276K 0.01% 1197
2015
Q2
$1.77M Buy
53,458
+18,651
+54% +$587K 0.01% 1395
2015
Q1
$1.12M Sell
34,807
-18,801
-35% -$607K ﹤0.01% 1597
2014
Q4
$1.66M Buy
+53,608
New +$1.59M 0.01% 1269

Other funds holding HCSG

Raymond James & Associates's HCSG Position: Q3 2024 in Review

Raymond James & Associates reduced its Healthcare Services Group (HCSG) stake by 3.8% in Q3 2024, selling an estimated $162K and leaving 369,137 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Raymond James & Associates first reported a position in HCSG in Q4 2014 and has held it in 40 quarters since. The position peaked at $23.9M in Q3 2017. 202 funds tracked by Wall St. Rank hold HCSG as of Q3 2024.

  • Raymond James & Associates held 369,137 shares of Healthcare Services Group worth $4.12M as of Q3 2024.
  • Raymond James & Associates sold 14,727 Healthcare Services Group shares in Q3 2024, an estimated $162K.
  • Healthcare Services Group made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1782 holding.
  • Raymond James & Associates first reported a position in Healthcare Services Group in Q4 2014 and has held it in 40 quarters since.
  • Raymond James & Associates's Healthcare Services Group position peaked at $23.9M in Q3 2017.
  • 202 funds tracked by Wall St. Rank held Healthcare Services Group as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.